Double-disk synergy test positivity in Stenotrophomonas maltophilia clinical strains

Folia Microbiologica

Volumn 49, Issue 1, 2004, Pages 71-74

  Hejnar, P ^a   Kolar M ^a   Chmela, Z ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

STENOTROPHOMONAS; STENOTROPHOMONAS MALTOPHILIA;

EID: 1842575832     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931649     Document Type: Article

References (18)

1. BLAHOVÁ J., KRÁLIKOVÁ K., KRČMÉRY V., TORŠOVÁ V.: Transferable antibiotic resistance in nosocomial Stenotrophomonas maltophilia strain. Diagn.Microbiol.Infect.Dis. 29, 129-132 (1997).
2. BLAHOVÁ J., HUPKOVÁ-LEŠICKÁ M., KRÁLIKOVÁ K., KRČMÉRY V.: Extended spectrum β-lactamase reactions in Stenotrophomonas maltophilia. Infection 26, 187-188 (1998).
3. CANTÓN R., VALDEZATE S., SANCHEZ DEL SAZ B., PÉREZ-VAZQUEZ M., OLIVER A., LOZA E., BAQUERO F.: Cef and β-lactamase inhibitor combinations against clinical isolates of Stenotrophomonas maltophilia. Clin.Microbiol.Infect. 5 (Suppl. 3), 370 (1999).
4. DENTON M., KERR K.G.: Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin.Microbiol.Rev. 11, 57-80 (1998).
5. FELICI A., AMICOSANTE G.: Kinetic analysis of extension of substrate specifity with Xanthomonas maltophilia, Aeromonas hydrophila, and Bacillus cereus metallo-β-lactamases. Antimicrob.Agents Chemother. 39, 192-199 (1995).
6. 2O-producing Xanthomonas-like isolates from biofilters as Stenotrophomonas nitritireducens sp.nov., Luteimonas mephitis gen.nov., sp.nov. and Pseudoxanthomonas broegbernensis gen.nov., sp.nov. Internat.J.Syst.Evol. Microbiol. 50, 273-282 (2000).
7. HEJNAR P., CHMELA Z., RYPKA M.: Fatty acid analysis of Stenotrophomonas maltophilia clinical strains showing different susceptibility to antibiotics at 30 and 37°C. Folia Microbiol. 47, 742-746 (2002).
8. JARLIER V., NICOLAS M.H., FOURNIER G., PHILIPPON A.: Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev.Infect.Dis. 10, 867-878 (1988).
9. KELLY M.D., MORTENSEN J.E., KONKLE B.A., STULL T.L.: A plasmid mediating production of a β-lactamase by Stenotrophomonas maltophilia. Curr.Ther.Res. 56, 152-162 (1995).
10. MUÑOZ BELLIDO J.L., GARCÍA-RODRIGUEZ J.A.: Azt-Cla synergy does not mean extended-spectrum β-lactamase in Stenotrophomonas maltophilia. J.Antimicrob.Chemother. 41, 493-497 (1998).
11. PANKUCH G.A., JACOBS M.R., RITTENHOUSE S.F., APPELBAUM P.C.: Susceptibilities of 123 strains of Xanthomonas maltophilia to eight β-lactams (including β-lactam-β-lactamase inhibitor combinations) and ciprofloxacin tested by five methods. Antimicrob.Agents Chemother. 38, 2317-2322 (1994).
12. PATON R., MILES R.S., AMYES S.G.B.: Biochemical properties of inducible β-lactamases produced from Xanthomonas maltophilia. Antimicrob.Agents Chemother. 38, 2143-2149 (1994).
13. PAYNE D.J., CRAMP R., BATESON J.H., NEALE J., KNOWLES D.: Rapid identification of metallo-and serine β-lactamases. Antimicrob. Agents Chemother. 38, 991-996 (1994).
14. PRADHANANGA S.L., ROWLING P.J.E., SIMPSON I.N., PAYNE D.J.: Sensitivity of L-2 type β-lactamases from Stenotrophomonas maltophilia to serine active site β-lactamase inhibitors. J.Antimicrob.Chemother. 37, 394-396 (1996).
15. SAINO Y., KOBAYASHI F., INOUE M., MITSUHASHI S.: Purification and properties of inducible penicillin β-lactamase isolated from Pseudomonas maltophilia. Antimicrob.Agents Chemother. 22, 564-570 (1982).
16. SAINO Y., INOUE M., MITSUHASHI S.: Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN 12873. Antimicrob.Agents Chemother. 25, 362-365 (1984).
17. TOWNSEND R., WINSTANLEY T.G., SPENCER R.C.: In vitro susceptibility of Xanthomonas maltophilia to Azt and Cla as a test for the presumptive identification of the species. J.Hosp.Infect. 18, 324-325 (1991).
18. VALDEZATE S., VINDEL A., LOZA E., BAQUERO F., CANTÓN R.: Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains. Antimicrob.Agents Chemother. 45, 1581-1584 (2001).